However, invasive glioma cells express ECM-degrading proteases, such as MMPs, ADAMs, urokinase-type plasminogen activator (uPA), and cathepsin B; invade tissue through complex proteolysis; and remodel the ECM microenvironment [5] (Figure 2). This evidence concerns the gene CTSB and glioma.